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Abstract
This study evaluated the effect of hydroxytamoxifen, the major active metabolite of tamoxifen (synthetic, nonsteroidal antiestrogen
drug), on the function of brain mitochondria. We observed that only high concentrations of hydroxytamoxifen (60 nmol/mg protein)
induced a significant decrease in RCR, while ADP/O ratio remained statistically unchanged. Similarly, only the highest concentration of
hydroxytamoxifen (60 nmol/mg protein) affected the phosphorylative capacity of brain mitochondria, characterized by a decrease in the
repolarization level and an increase in the repolarization lag phase. We observed that all the concentrations of hydroxytamoxifen tested
(7.5, 15 and 30 nmol/mg protein) prevented lipid peroxidation induced by the oxidant pair ADP/Fe2þ. Furthermore, through the analyses
of calcium fluxes and mitochondrial transmembrane potential parameters, we observed that hydroxytamoxifen (30 nmol/mg protein)
exerted some protection against pore opening, although in a less extension than that promoted by cyclosporin A, the specific inhibitor of
the mitochondrial permeability transition pore. However, in the presence of hydroxytamoxifen plus cyclosporin A, the protection observed
was significantly higher when compared with that induced by both agents alone.
These results support the idea that hydroxytamoxifen protects lipid peroxidation and inhibits the mitochondrial permeability transition
pore in brain. Since numerous neurodegenerative diseases are intimately related with mitochondrial dysfunction resulting from lipid
peroxidation and induction of mitochondrial permeability transition, among other factors, future therapeutical strategies could be
designed taking in account this neuroprotective role of hydroxytamoxifen, which is pharmacologically much more potent and less toxic
than its promoter tamoxifen.
# 2004 Elsevier Inc. All rights reserved.
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1. Introduction
Tamoxifen (TAM) is a non-steroidal estrogenic com-
pound used for the treatment of breast cancer. It is a first-
generation selective estrogen receptor modulator (SERM)
and acts as an estrogen antagonist in mammary tissue but
mimics the effects of estrogen in other tissues [1]. TAM
undergoes extensive hepatic metabolism being hydroxy-
tamoxifen (OHTAM) its major active metabolite and
responsible for its antiestrogenic activity [2]. Besides their
chemopreventing function, TAM and OHTAM, which are
extremelly lipophilic [3,4], induce multiple cellular effects,
including antioxidant actions since they are strong intra-
membranous scavengers of peroxyl radicals [5].
TAM and OHTAM can penetrate the blood brain barrier
and interact with several neuronal estrogen receptor-posi-
tive cell populations [6,7]. Previous studies in vitro [8]
showed that OHTAM has a higher affinity for the estrogen
receptor than TAM. Furthermore, OHTAM is 100- to 200-
times more potent [9,10] and it is pharmacologically well
tolerated [11] and less toxic to erythrocytes [12] and to
sarcoplasmic reticulum calcium pump [13]. Dietze and
collaborators [14] also reported that OHTAM, in contrast
to TAM, do not induce apoptosis in p53() human mam-
mary epithelial cells. Although most studies of TAM and
its metabolites have been focused on its ability to compete
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with estrogens for binding to its receptors, several recent
studies have described additional estrogen receptor-inde-
pendent activities of TAM [15,16].
Data from the literature point for a neuroprotective role
associated to TAM and OHTAM being the study of TAM
effects more explored. Previous studies have shown that
TAM is effective in protecting brain tissue from rat models
of reversible and permanent focal ischemia [17,18] and
suppress the HO generation via dopamine efflux induced
by MPPþ [19]. O’Neill and Brinton [20] showed that both
TAM and OHTAM attenuate the excitotoxic glutamate-
induced intracellular Ca2þ rise.
It has become clear that mitochondria have a significant
role to play not only in energy production, but also in cell
death [21]. A potentially central factor in cell death in
neurodegeneration is the mitochondrial permeability tran-
sition pore (MPTP) [22,23]. The MPTP is a phenomenon
that is characterized by the opening of pores in the inner
mitochondrial membrane and by its sensitivity to a very
low concentration of cyclosporin A (CsA). Ca2þ and
oxidative stress have long been known to favor the perme-
ability transition [24].
Previous studies indicate that TAM [25] and OHTAM
[26] are potent inhibitors of the MPTP in liver mitochondria.
Furthermore, Hoyt et al. [27] reported that TAM could be an
inhibitor of the MPTP in intact neurons. Our first goal was
the evaluation of the impact of increasing concentrations of
OHTAM (15, 30, 60 nmol/mg protein) in the respiratory
chain and oxidative phosphorylation system. For that pur-
posewe analysed the respiratory indexes (RCR and ADP/O),
mitochondrial transmembrane potential (DCm), repolariza-
tion level, repolarization lag phase and ATP levels. The
second part of this study was aimed to evaluate the protective
effect of OHTAM in the lipid peroxidation induced by the
pair ADP/Fe2þ and in the induction of MPTP by Ca2þ. Lipid
peroxidation was evaluated by oxygen consumption and
TBARS formation. MPTP induction was characterized
by analyzing the mitochondrial DCm, calcium fluxes and
glutathione content.
2. Materials and methods
2.1. Materials
Hydroxytamoxifen and Protease type VIII (Subtilisin
Carlsberg) were obtained from Sigma (St. Louis, MO).
Digitonin was obtained from Calbiochem (Merck Bios-
ciences Ltd., Nottingham). All the other chemicals were of
the highest grade of purity commercially available.
2.2. Animals
Male Wistar rats (3 months old) were housed in our
animal colony (Laboratory Research Center, University
Hospital, Coimbra, Portugal). They were maintained under
controlled light (12 h day/night cycle) and humidity with
free access to water (except in the fasting period) and
powdered rodent chow (URF1-Charles River, France).
Adhering to procedures approved by the Institutional
Animal Care and Use Committee, the animals were sacri-
ficed by cervical displacement and decapitation.
2.3. Isolation of brain mitochondria
Brain mitochondria were isolated from male Wistar by
the method of Rosenthal et al. [28], with slight modifica-
tions, using 0.02% digitonin to free mitochondria from the
synaptosomal fraction. In brief, one rat is decapitated, and
the whole brain minus the cerebellum was rapidly
removed, washed, minced, and homogenised at 4 8C in
10 ml of isolation medium (225 mM mannitol, 75 mM
sucrose, 5 mM Hepes, 1 mM EGTA, 1 mg/ml bovine
serum albumin, pH 7.4) containing 5 mg of the bacterial
protease. Single brain homogenates were brought to 30 ml
and then centrifuged at 2500 rpm (Sorvall RC-5B Refri-
gerated Superspeed Centrifuge) for 5 min. The pellet,
including the fluffy synaptosomal layer, was resuspended
in 10 ml of the isolation medium containing 0.02% digi-
tonin and centrifuged at 10,000 rpm for 8 min. The brown
mitochondrial pellet without the synaptosomal layer was
then resuspended again in 10 ml of medium and recen-
trifuged at 10,000 rpm for 10 min. The mitochondrial
pellet was resuspended in 300 ml of resuspension medium
(225 mM mannitol, 75 mM sucrose, 5 mM Hepes, pH 7.4).
Mitochondrial protein was determined by the biuret
method calibrated with bovine serum albumin [29].
2.4. Mitochondrial respiration measurements
Oxygen consumption of isolated mitochondria was
monitored polarographically with a Clark oxygen elec-
trode (YSI Model 5331, Yellow Springs Inst.) [30] con-
nected to a suitable recorder in a 1 ml thermostated water-
jacketed closed chamber with magnetic stirring. The reac-
tions were carried out at 30 8C in 1 ml of the reaction
medium (100 mM sucrose, 100 mM KCl, 2 mM KH2PO4,
5 mM Hepes, 10 mM EGTA, pH 7.4) with 0.6 mg protein.
The isolates were incubated with OHTAM for 2 min before
succinate addition. ADP (125 nmol/mg protein) was added
after energization of mitochondria.
2.5. Membrane potential (DCm) measurements
The mitochondrial transmembrane potential was mon-
itored by evaluating the transmembrane distribution of
tetraphenylphosphonium (TPPþ) with a TPPþ-selective
electrode prepared according to Kamo et al. [31] using
an Ag/AgCl2 electrode as reference.
Reactions were carried out in a chamber with magnetic
stirring in 1 ml of reaction medium supplemented with
3 mM TPPþ. The experiments were started by adding 5 mM
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succinate to mitochondria in suspension at 0.6 mg protein/
ml. Membrane potential was estimated from the decrease
on TPPþ concentration in the reaction medium as
described elsewhere [32]. The isolates were incubated with
OHTAM for 2 min before succinate addition. In the MPTP
experiments, after a steady-state distribution of TPPþ had
been reached (2 min of recording), Ca2þ was added and
DCm recorded.
2.6. Analysis of ATP content
At the end of the DCm experiments, 250 ml of each
mitochondrial suspension were rapidly centrifuged at
14,000 rpm (Eppendorf Centrifuge 5415C) for 4 min with
0.3 M perchloric acid. The supernatants were neutralised
with 10 M KOH in 5 M Tris and centrifuged at 14,000 rpm
(Eppendorf Centrifuge 5415C) for 4 min. The resulting
supernatants were assayed for ATP by separation in a
reverse-phase high performance liquid chromatography.
The chromatography apparatus was a Beckman-System
Gold, consisting of a 126 Binary Pump Model and 166
Variable UV detector controlled by a computer. The detec-
tion wavelength was 254 nm, and the column was a Lichro-
spher 100 RP-18 (5 mm) from Merck. An isocratic elution
with 100 mM phosphate buffer (KH2PO4) pH 6.5 and 1.0%
methanol was performed with a flow rate of 1 ml/min. The
required time for each analysis was 6 min.
2.7. Lipid peroxidation
The extent of lipid peroxidation was evaluated by oxy-
gen consumption using a Clark-type electrode (YSI Model
5331, Yellow Springs Inst.) in a closed glass chamber
equipped with magnetic stirring, thermostated at 30 8C,
as described by Dinis et al. [33]. Reactions were started by
the addition of ADP/Fe2þ. The changes in O2 tension were
recorded in a potentiometric chart recorder and the oxygen
consumption calculated assuming an oxygen concentration
of 236 nmol O2/ml. OHTAM was introduced in the incu-
bation medium, containing mitochondria, 2 min before the
addition of ADP/Fe2þ.
Lipid peroxidation was also determined by measuring
thiobarbituric acid reactive substances (TBARS), using the
thiobarbituric acid assay (TBA), according to a modified
procedure described by Ernster and Nordenbrand [34]. The
amount of TBARS formed was calculated using a molar
coefficient of 1:56 105 mol1 cm1 and expressed as
nmol TBARS/mg protein.
2.8. Calcium fluxes
Mitochondrial calcium fluxes were measured by mon-
itoring the changes in Ca2þ concentration in the reaction
medium using a calcium-selective electrode according to
previously described procedures [32]. The reactions were
conducted in an openvessel with magnetic stirring in 1 ml of
the reaction medium containing 100 mM sucrose, 100 mM
KCl, 2 mM KH2PO4, 10 mM EGTA, 5 mM Hepes (pH 7.4),
with 2 mM rotenone. Mitochondria (0.8 mg/ml) were ener-
gized with 5 mM succinate after 1 min of Ca2þ addition.
30 nmol OHTAM/mg protein, 0.85 mM CsA and 2 mg/ml
oligomycin plus 1 mM ADP were added to the reaction
medium 2 min prior Ca2þ addition. In CsA plus OHTAM
condition, CsA was added after mitochondria energization.
2.9. Glutathione content
Reduced (GSH) and oxidized (GSSG) glutathione were
determined with fluorescence detection after reaction of
the supernatant of the H3PO4/EDTA-NaH2PO4 or H3PO4/
NaOH deproteinized mitochondria solution, respectively,
with o-phthalaldehyde (OPT), pH 8.0, according to Hissin
and Hilf [35]. In brief, at the end of the DCm experiments,
500 ml of each mitochondrial suspension were rapidly
centrifuged at 50,000 rpm (Beckman, TL-100 Ultracentri-
fuge) for 30 min with 1.5 ml phosphate buffer (100 mM
NaH2PO4, 5 mM EDTA, pH 8.0) and 500 ml H3PO4 2.5%.
For GSH determination 100 ml of the supernatant were
added to 1.8 ml phosphate buffer and 100 ml OPT. After
mixing and incubation at room temperature for 15 min, the
solution was transferred to a quartz cuvette and the fluor-
escence was measured at 420 nm. For GSSG determination
250 ml of the supernatant were added to 100 ml of N-
ethylmaleymide and incubated at room temperature for
30 min. After the incubation 140 ml of the mixture were
added to 1.76 ml NaOH (100 mM) buffer and 100 ml OPT.
After mixing and incubation at room temperature for
15 min, the solution was transferred to a quartz cuvette
and the fluorescence was measured at 420 and 350 nm
emission and excitation wavelength, respectively (slits 5,
5). The GSH and GSSG contents were determined from
comparisons with a linear reduced or oxidized glutathione
standard curve, respectively.
2.10. Statistical analysis
Results are presented as mean S:E:M: of the indicated
number of experiments. Statistical significance was deter-
mined by using the one-way ANOVA test for multiple
comparisons, followed by the post hoc Tukey–Kramer test
or by the unpaired two-tailed Student’s t-test.
3. Results
3.1. Effect of OHTAM in brain mitochondrial
respiration
Respiratory control ratio (RCR) is the ratio between
mitochondrial respiration states 3 (consumption of oxygen
in the presence of substrate and ADP) and 4 (consumption
of oxygen after ADP has been consumed). Only the higher
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concentration of OHTAM (60 nmol/mg protein) induced a
significant decrease on RCR when compared with control
condition (30:49% 1:35) as well as when compared
with 15 nmol OHTAM/mg protein (32:11% 1:16) and
30 nmol OHTAM/mg protein (21:40% 0:40) (Fig. 1).
ADP/O ratio, an indicator of oxidative phosphorylation
efficiency, is expressed by the ratio between the amount
of ADP added and the oxygen consumed during the state
3 of respiration. This parameter remained statistically
unchanged in all the conditions studied (Fig. 1).
3.2. Effect of OHTAM in brain mitochondrial
transmembrane potencial (DCm), repolarization level,
repolarization lag phase and ATP content
The mitochondrial transmembrane potential (DCm) is
fundamental for the phenomenon of oxidative phosphor-
ylation, the conversion of ADP to ATP via ATP synthase.
Mitochondrial respiratory chain pumps Hþ out of the
mitochondrial matrix across the inner mitochondrial mem-
brane. The Hþ gradient originates an electrochemical
potential (Dp) resulting in a pH (DpH) and a voltage
gradient (DCm) across the mitochondrial inner membrane.
As shown in Table 1, DCm remained unchanged in all the
conditions tested. However, the repolarization level (capa-
city of mitochondria to reestablish the DCm, after ADP
phosphorylation) decreased significantly in the presence of
60 nmol OHTAM/mg protein when compared with all the
other conditions tested (Table 1). Accordingly, the repo-
larization lag phase (time necessary for ADP phosphoryla-
tion) increased significantly in the presence of the highest
OHTAM concentration tested.
Concerning the ATP content, we did not observe any
significant alteration promoted by OHTAM. Although the
presence of 60 nmol OHTAM/mg protein slowed the oxi-
dative phosphorylation capacity of brain mitochondria
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Fig. 1. Effect of OHTAM in respiratory control indexes (RCR and ADP/O ratio) of brain mitochondria. Freshly isolated brain mitochondria (0.6 mg) in 1 ml
of the standard medium supplemented with 2 mM rotenone were energized with 5 mM succinate. Isolates were incubated with OHTAM for 2 min, at 30 8C,
before mitochondria energization. Results are presented as mean S:E:M: of six independent experiments. (***) P < 0:001, when compared with
mitochondria in control condition. (###) P < 0:001, when compared with mitochondria incubated with 15 nmol OHTAM /mg protein. ($) P < 0:05, when
compared with mitochondria incubated with 30 nmol OHTAM/mg protein.
Table 1
Effect of OHTAM in the mitochondrial oxidative phosphorylation system (mitochondrial transmembrane potential (DCm), repolarization level, repolarization
lag phase and ATP content)
Control OHTAM (15 nmol/mg prot) OHTAM (30 nmol/mg prot) OHTAM (60 nmol/mg prot)
DCm (mV) 186.6  1.83 184.9  2.36 183.5  2.51 175.9  3.06
Repolarization level (mV) 157.5  2.18 152.9  1.69 151.0  1.98 139.6  2.29***,##,$$
Repolarization lag phase (min) 0.558  0.05 0.588  0.051 0.738  0.036 0.922  0.071***,##
ATP content (nmol/mg protein) 285.9  17.75 279.5  12.85 243.5  13.33 272.4  19.69
The oxidative phosphorylation parameters were evaluated using freshly isolated brain mitochondria (0.6 mg) in 1 ml of the reaction medium supplemented
with 3 mM TPPþ and 2 mM rotenone and energized with 5 mM succinate.
*** P < 0:001, statistically significant when compared to control condition.
## P < 0:01, statistically significant when compared to 15 nmol OHTAM/mg protein.
$$ P < 0:01, statistically significant when compared to 30 nmol OHTAM/mg protein. Data shown represent mean S:E:M: from six independent
experiments.
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(increase in repolarization lag phase and decrease in
repolarization level) they were capable to phosphorylate
all the ADP added to mitochondrial suspension.
3.3. Effect of OHTAM on lipid peroxidation: oxygen
consumption and TBARS formation
The oxygen consumption and TBARS assay were used
to determine the level of lipid peroxidation induced by
ADP/Fe2þ. The maximal values of oxygen consumption
(Fig. 2A) and TBARS formation (Fig. 2B), observed at
15 min of peroxidation, were 172:8 23:79 nmol/mg
protein and 22:75 3:53 nmol TBARS/mg protein,
respectively. Inhibition of oxygen consumption and
TBARS formation was observed in the presence of all
the concentrations of OHTAM tested (Fig. 2A and B).
Although a concentration-dependent protection was obser-
ved, the presence of 7.5 nmol OHTAM/mg protein
afforded a clear protection being the extension of lipid
peroxidation not statistically different when compared
with the other concentrations of OHTAM tested as well
as when compared with the control condition.
3.4. Effect of OHTAM on the mitochondrial permeability
transition pore (MPTP): DCm and calcium fluxes
The mitochondrial potential (DCm) drop is a typical
phenomenon that follows the induction of MPTP. In con-
trol conditions (Fig. 3A), the addition of 5 mM succinate
produced an DCm of185 mV (negative inside mitochon-
dria), corresponding to the respiratory state 4. Then, the
first pulse of 10 mM Ca2þ led to a rapid depolarization
(decrease of DCm) followed by a small repolarization
(recover of DCm). The depolarization was due to the entry
of Ca2þ into the electronegative mitochondrial matrix,
followed by the efflux of Hþ in an attempt to restore
the DCm. However, a second and third pulse of 10 mM
Ca2þ led to a total depolarization of mitochondria. Mito-
chondria can tolerate some amount of Ca2þ, but ultimately
their capacity to adapt to Ca2þ loads is overwhelmed and
mitochondria depolarize completely due to a profound
change in the inner membrane permeability. Since the
mitochondrial collapse of DCm, associated to Ca
2þ over-
load, is related with MPTP opening, experiments were
performed to further confirm the induction of the MPTP
opening by studying the Ca2þ retention by energized
mitochondria. Fig. 4 shows that isolated brain mitochon-
dria incubated with 100 nmol Ca2þ/mg protein in the
presence of 2 mM phosphate and energized with succinate,
rapidly accumulate Ca2þ from the medium and, after a
slow release of some of the accumulated Ca2þ, they were
able to continue to accumulate Ca2þ, thus retaining part of
the Ca2þ present in the medium. In the presence of 50 nmol
Ca2þ/mg protein mitochondria retained a large portion of
this cation, however in the presence of 150 nmol Ca2þ/mg
protein mitochondria became unable to retain the accu-
mulated Ca2þ due to MPTP opening (Fig. 4A).
These effects on calcium accumulation could be pre-
vented in the presence of 0.85 mM CsA and 1 mM ADP
plus 2 mg/ml oligomycin. Although both agents contrib-
uted for a higher capacity of mitochondria to accumulate
Ca2þ, the protection exerted by ADP plus oligomycin was
more effective than that exert by CsA (Figs. 3B, C and 4).
The presence of 30 nmol OHTAM/mg protein (2 min pre-
incubation) exerted some protection against mitochondrial
membrane depolarization and calcium release, by in-
creasing the capacity of mitochondria to acumulate
Ca2þ (Figs. 3B and 4B). Additionally, the presence of
0.85 mM cyclosporin A (CsA) (specific inhibitor of MPTP)
Fig. 2. Effect of OHTAM on lipid peroxidation: oxygen consumption (A)
and TBARS formation (B). Freshly isolated brain mitochondria were
incubated at 0.6 mg protein/ml under standard conditions as described in
Section 2. Isolates were pre-incubated with OHTAM for 2 min, at 30 8C,
before the addition of ADP-Fe2þ. Results are presented as mean S:E:M:
of six independent experiments. (*) P < 0:05, when compared with
mitochondria in control condition. (###) P < 0:001; (##) P < 0:01; (#)
P < 0:05; when compared with mitochondria incubated with 30 mM Ca2þ.
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added 2 min prior to Ca2þ, afforded a clear protection of
mitochondria (Figs. 3C and 4). However, in the presence of
both agents, 30 nmol OHTAM/mg protein and 0.85 mM
CsA, the capacity of mitochondria to accumulate Ca2þ
increased significantly being mitochondria more resistant
to Ca2þ addition and, consequently, to MPTP induction
(Figs. 3D and 4B).
3.5. Effect of OHTAM on the mitochondrial
glutathione content
Theoretically, the opening of MPTP is stimulated by the
alteration of GSH redox status (–SH ! –SS–). We
observed that Ca2þ induced a decrease in GSH (reduced
glutathione) which was reversed in the presence of 30 nmol
OHTAM/mg protein and/or CsA. However, GSSG
(oxidized glutathione) did not change in all the conditions
studied (Fig. 5). The decrease induced by Ca2þ in GSH was
confirmed by the significant decrease of GSH/GSSG ratio
being this decrease reverted by the presence of 30 nmol
OHTAM /mg protein and/or CsA (Fig. 5).
4. Discussion
Several evidences from the literature indicate that
mitochondria have a significant role to play not only in
routine energy metabolism, but also in cell death [21].
Neurons are structures extremely susceptible to mito-
chondrial dysfunction since about 90% of the energy
required by these cells is provided by mitochondria. In
this order, the search of new compounds capable to
protect mitochondria against toxic and/or stressful agents
has become an important goal for many scientists work-
ing in this research area.
In this study the effect of OHTAM in brain mitochon-
drial function was evaluated. We observed that only higher
concentrations of OHTAM (60 nmol/mg protein) promote
a decrease in respiratory chain and oxidative phosphoryla-
tion efficiencies (Fig. 1, Table 1). In accordance, Cardoso
et al. [36] observed that OHTAM decreases the respiratory
coefficient and the ADP/O ratio of liver mitochondria in a
concentration-dependent way. However, this depression of
respiratory indexes was significant for concentrations
above 40 nmol OHTAM/mg protein. Furthermore, they
also observed that concentrations of OHTAM >
40 nmol/mg protein increases the lag phase of repolariza-
tion and decreases the rate of repolarization. Similarly, we
observed a decrease on repolarization level and an increase
on repolarization lag phase although these alterations
occurred in the presence of higher OHTAM concentrations
(60 nmol OHTAM/mg protein) (Table 1). The discrepan-
cies in the concentrations of OHTAM in both studies are
probably due to the different type of mitochondria used.
Fig. 3. Effect of OHTAM on mitochondrial transmembrane potential depolarization: permeability transition pore induction. Freshly isolated brain
mitochondria (0.6 mg) in 1 ml of the standard medium supplemented with 3 mM TPPþ and 2 mM rotenone were energized with 5 mM succinate. (A) Control
condition; (B) 30 nmol OHTAM/mg protein; (C) 0.85 mM CsA; (D) 30 nmol OHTAM/mg protein plus 0.85 mM CsA. Isolates were pre-incubated with
OHTAM and/or CsA for 2 min before mitochondria energization with succinate. Ca2þ (3 10 mM) was added 1.5 min after mitochondria energization. The
traces are typical of six independent experiments.
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The existence of tissue-specific differences in mitochon-
dria properties has been described [37,38].
Our results indicate that although a decrease in oxidative
phosphorylation efficiency occurs in the presence of high
concentrations of OHTAM, it do not interfere with ATP
content of brain mitochondria (Table 1). Recently, Cardoso
et al. [39] showed that only concentrations of OHTAM
above 60 nmol/mg protein decrease ATP content of liver
mitochondria.
However, OHTAM has shown to be a powerful antiox-
idant, protecting brain mitochondria against ADP/Fe2þ-
induced lipid peroxidation. Our results show that OHTAM
exert a potent antioxidant action since 7.5 nmol OHTAM/
mg protein was sufficient to reduce oxygen consumption
(Fig. 2A) and TBARS levels (Fig. 2B) to values similar to
those found in control condition (basal values). It has been
described that OHTAM is a scavenger of peroxyl radicals
in several cells and systems. OHTAM inhibits lipid per-
oxidation in sarcoplasmic reticulum membranes [5] and
Fe3þ-ascorbate-induced lipid peroxidation in rat liver
microsomes [40]. Furthermore, the ability of TAM and
OHTAM to inhibit Cu2þ-induced peroxidation of low-
density lipoprotein has been suggested to contribute to
the putative cardioprotective effects of these antiestrogens
[41]. Raghvendra and coworkers [42] demonstrated that
estrogen and tamoxifen metabolites protect smooth muscle
cell membrane phospholipids against peroxidation via a
non-estrogen receptor-dependent mechanism. A study
from O’Neill et al. [43] showed that raloxifene (estrogen
receptor modulator) at low concentrations (50 ng/ml)
induces a significant neuroprotection against b-amyloid-,
H2O2- and glutamate-induced toxicity. However, the same
study showed that raloxifene exerts partial estrogen agonist
action in the absence of 17 b-estradiol whereas in its
presence raloxifene exerted a mixed estrogen agonist-
antagonist effect. Similarly, Lei et al. [44] found that
estrogen and raloxifene can influence glial-mediated
inflammatory pathways and possibly protecting against
age- and disease-related neuropathology. However, there
are some evidences that TAM and OHTAM are associated
with intracellular oxidative stress [45,46]. These discre-
pancies can be due to differences in the concentrations of
TAM and OHTAM and/or experimental models used.
Indeed, some animal studies indicate the existence of
dose-related biphasic effects of estradiol [47,48]. Some
effects are lost at higher concentrations [47,48], whereas
others require high doses [49]. These dose-related effects
could be taken as an advantage to possibly dissociate some
activities in the target tissue. It is possible that a similar
picture occurred with antiestrogen compounds.
Since previous studies [26] demonstrated the inhibitory
effect of OHTAM on MPTP induction, we tested the effect
of OHTAM on Ca2þ-induced MPTP of isolated brain
mitochondria. MPTP causes a non-selective permeabiliza-
tion of the inner mitochondrial membrane typically pro-
moted by the accumulation of excessive quantities of Ca2þ
ions and stimulated by a variety of compounds or condi-
tions [24]. In this study, the classic inductor Ca2þ was used
to induce MPTP opening (Figs. 3 and 4). Ca2þ uptake is
concentration-dependent, with higher concentrations lead-
ing to a lower amount of Ca2þ being accumulated by
mitochondria, indicating a continuous cycling of Ca2þ
due to MPTP induction. The pore opening allows the
equilibration of ions and respiratory substrate between
cytosol and mitochondrial matrix leading to a reduction
on DCm [50], which is linked to depletion of GSH [51].
Indeed, mitochondrial pore induction is intimately asso-
ciated with GSH and protein thiol redox state [52]. Glu-
tathione is the most abundant antioxidant in the cell.
Regeneration of GSH from GSSG occurs in matrix. Con-
tinued regeneration of GSH requires NADPH, which in
turn requires transhydrogenation of NADPþ and NADH. In
our study, we observed that Ca2þ induced a significant
decrease in GSH/GSSG ratio due to a decrease in GSH
Fig. 4. Effect of OHTAM on calcium fluxes. Mitochondria were incubated
at 0.8 mg protein/ml under standard conditions as described in Section 2.
Standard medium was supplemented with Ca2þ 1 min before mitochondria
energization with 5 mM succinate. 30 nmol OHTAM/mg protein, 0.85 mM
CsA and 2 mg/ml oligomycin plus 1 mM ADP were added to the reaction
medium 2 min prior Ca2þ addition. In CsA plus OHTAM condition, CsA
was added after mitochondria energization. The uptake and release of
sequestered Ca2þ by mitochondria were monitored as described in Section
2. The traces are typical of six independent experiments.
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content since no alteration in GSSG content was observed
(Fig. 5). Similarly, Custo´dio et al. [25] showed that the loss
of matrix GSH from liver mitochondria is attributed to its
release to the medium since no GSSG was detected in any
of the reactions and since the total GSH (intra and extra-
mitochondrial) did not change. So, the depletion of GSH
was solely due to the efflux from the permeabilized
mitochondria, which was prevented by cyclosporin A
and hydroxytamoxifen (Fig. 5).
The presence of 30 nmol OHTAM/mg protein exerted
some protection against Ca2þ-induced MPTP opening
(Figs. 3B and 4B). Our results are supported by the
observations of Morkuniene et al. [53] that OHTAM
prevented calcium-induced loss of cytochrome c from
heart mitochondria. In our study, CsA does not give a
total protection against MPTP induction, however, it
increases the capacity of brain mitochondria to accumu-
late Ca2þ (Figs. 3C and 4). Simpson et al. [54] observed
that TAM exerted a CsA-like action on SH-SY5Y neu-
roblastoma mitochondria. Similarly, Cardoso et al. [26]
observed that 20 mM OHTAM caused a total inhibition of
Ca2þ-induced depolarization of succinate-energized liver
mitochondria similar to that exerted by CsA. As dis-
cussed previously, due to tissue-specific differences in
mitochondria pore properties [37], the ability of both
agents, OHTAM and CsA, to protect against MPTP
induction differs significantly between different types
of mitochondria. The effect of CsA on the ability of
brain mitochondria to accumulate Ca2þ was only mod-
erate when compared with the effects described for CsA
on muscle or liver mitochondria [38,55]. Similar effects
of CsA were also reported on cell lines [56] and neuronal
primary cultures [57]. Another study performed in a
neuronal primary culture showed that mitochondrial
depolarization induced by glutamate was partially inhib-
ited by TAM [27]. Interestingly, 30 nmol OHTAM/mg
protein plus CsA exerted a higher protection against
MPTP opening (Fig. 3D and 4B) when compared with
the protection exerted by each agent alone (Fig. 3B, C
and 4). These results indicate that the effects of both
agents are not additive, suggesting that they act at
different places on mitochondrial pore complex. The
most plausible hypothesis concerning MPTP inhibition
by CsA is that cyclophilin D binding to the matrix side of
the MPTP favors its opening and that CsA indirectly
causes pore closure through unbinding of cyclophilin D
after formation of the CsA-cyclophilin complex [58]. In
turn, MPTP inhibition by OHTAM may be due to its
antioxidant properties [5]. This hypothesis is supported
by our results that show that OHTAM exerts potent
antioxidant effects against lipid peroxidation (Fig. 2A
and B).
Our results support the idea that the neuroprotective role
of OHTAM is primarily due to its antioxidant-like actions.
However, we cannot rule out its capacity in MPTP inhibi-
tion, especially in the presence of CsA, exacerbating its
inhibitory effect in MPTP induction. In this order, new
therapeutic strategies can be designed for the treatment of
neurodegenerative disorders where mitochondrial dysfunc-
tion, resulting among other factors from lipid peroxidation
and MPTP induction, may have a determinant role in
neuronal cell degeneration and death.
Fig. 5. Effect of OHTAM on mitochondrial GSH content. Freshly isolated brain mitochondria (0.6 mg) in 1 ml of the standard medium supplemented with
2 mM rotenone were energized with 5 mM succinate. Isolates were pre-incubated with OHTAM and/or CsA for 2 min, at 30 8C, before mitochondria
energization. Ca2þ was added after mitochondria energization. Results are presented as mean S:E:M: of six independent experiments.
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